XGN
Exagen Inc
8.50$
+3.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6.5% | -10.8% | -3.0% | -11.6% | +2.5% | -9.8% | +45.8% | +6.9% | -7.6% | -10.5% | 0.0% | |
| – | -2.2% | -11.4% | -3.8% | -12.8% | +2.5% | -10.8% | +56.9% | +3.1% | -7.0% | -10.9% | -1.7% | |
| – | +28.3% | -25.3% | -10.2% | -10.0% | +0.0% | -49.2% | +168.3% | +18.7% | -9.6% | -33.2% | +14.3% | |
| – | +28.3% | -25.3% | -10.2% | -10.0% | +0.0% | -49.2% | +168.3% | +18.7% | -9.6% | -33.2% | +14.3% | |
| – | -61.6% | +66.4% | +7.4% | -19.8% | -16.5% | +88.0% | +4.6% | -28.0% | -2.1% | +45.3% | -21.3% | |
| – | +28.2% | -26.9% | +36.9% | +2.1% | – | – | – | – | – | – | – | |
| – | +2.5% | -10.0% | +2.9% | -3.1% | +14.4% | -3.6% | +11.3% | +18.4% | -9.2% | -7.5% | +5.8% | |
| – | +17.6% | -26.2% | +7.5% | -7.1% | +53.9% | +3.6% | -26.4% | +25.2% | +9.8% | -11.3% | +7.1% | |
| – | -35.9% | +38.0% | +6.4% | -2.3% | -3.3% | +112.9% | -50.1% | +64.5% | -0.1% | -1.7% | -45.5% | |
| – | +89.0% | -53.1% | +58.5% | -52.6% | +274.4% | +9.0% | -44.3% | +41.8% | +16.7% | +0.1% | +6.7% | |
| – | +0.2% | +0.2% | +2.9% | 0.0% | 0.0% | -7.1% | +21.2% | -0.2% | +0.0% | +0.1% | +0.1% | |
| – | -17.5% | -11.9% | -12.0% | -26.8% | -25.9% | -32.9% | +228.5% | -13.8% | -3.8% | -17.3% | -15.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.8% | +0.6% | +1.3% | +0.4% | -0.3% | +1.9% | +13.6% | +8.8% | -6.0% | +10.7% | +1.3% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.